Related Experiment Video
Updated: Oct 9, 2025
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Study on Risk Factors for Death from Cardiomyopathy and Effectiveness of Health Information Management
Lei Wang1, Shuping Zhang2, Yan Wang2
1Special Inspection Section, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, China.
Insights
Older age, lower left ventricular ejection fraction (LVEF), and higher APACHE II/SOFA scores are risk factors for cardiomyopathy death. LVEF below 24.69% independently predicts mortality, while health information management improves short-term outcomes.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Health Informatics
Background:
- Cardiomyopathy is a leading cause of mortality, necessitating identification of risk factors and effective management strategies.
- Health Information Management (HIM) offers potential for improving patient outcomes in critical care settings.
Purpose of the Study:
- To identify risk factors associated with mortality in cardiomyopathy patients.
- To evaluate the effectiveness of Health Information Management (HIM) in improving treatment outcomes.
Main Methods:
- Retrospective analysis of clinical data from 80 cardiomyopathy patients admitted to ICU between January 2016 and January 2020.
- Patients were categorized into survival and death groups; the survival group was further divided into conventional and HIM groups for comparative analysis.
Main Results:
- Older age, lower left ventricular ejection fraction (LVEF), and higher APACHE II/SOFA scores were significantly associated with mortality.
- LVEF below 24.69% demonstrated high predictive value for death (sensitivity 98.6%, specificity 78.6%).
- HIM group showed improved disease remission, reduced complications, higher health knowledge awareness, shorter ICU stays, and better self-management efficacy compared to the conventional group, though 5-year survival rates were similar.
Conclusions:
- Older age, reduced LVEF, and elevated APACHE II/SOFA scores are critical risk factors for cardiomyopathy mortality.
- LVEF is an independent predictor of death, with values below 24.69% indicating significantly increased risk.
- HIM effectively enhances short-term treatment efficacy but does not significantly impact long-term survival rates.
Objective:
To explore risk factors for death from cardiomyopathy and the effectiveness of health information management (HIM).
Methods:
A total of 80 patients with cardiomyopathy admitted in ICU of our hospital (January 2016-January 2020) were selected as study subjects, and the clinical data of the patients were retrospectively analyzed. The patients were divided into the survival group (n = 72) and the death group (n = 14) according to the treatment outcome. Then, according to the management mode, the survival group was further equally divided into the conventional group and the HIM group to investigate the influence of risk factors on prognosis of patients with cardiomyopathy and the effectiveness of HIM.
Results:
No significant difference was found in baseline body mass, myocardial enzymes, troponin, infection factors, history of heart disease, and gender between the survival group and the death group (P > 0.05). Compared with the survival group, the patients of the death group were older (P < 0.05), LVEF of the death group was obviously lower (P < 0.05), and the scores of APACHE II and SOFA of the death group were obviously higher (P < 0.05). Further logistic regression analysis of the univariate factors influencing the risk of death from cardiomyopathy led to the conclusion that LVEF was an independent risk factor for death in patients with cardiomyopathy. LVEF below 24.69% examined by echocardiography had a high predictive value, with a sensitivity of 98.6% and a specificity of 78.6%. No obvious difference was found in general data between the conventional group and the HIM group (P > 0.05). Compared with the conventional group, the disease remission rate, complication rate, awareness rate of health knowledge, ICU length of stay, and scores of self-management efficacy of the HIM group were obviously better (P < 0.05). No significant difference was found in 5-year mean survival rate between the conventional group and the HIM group (P > 0.05).
Conclusion:
Older age, lower LVEF, and higher scores of APACHE II and SOFA are all risk factors for death from cardiomyopathy. Lower LVEF is an independent risk factor, and LVEF below 24.69% is an important indicator of increased risk of death. Moreover, HIM can effectively improve short-term treatment efficacy but has little effect on the long-term survival rate.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy VI: Nursing Management
01:27Heart Failure I: Introduction
01:25Cardiomyopathy I: Introduction and Classification